Holen Sie sich die Stockscreener-App
188.68
2.60%
4.79
Handel nachbörslich:
188.46
-0.22
-0.12%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$183.89
Offen:
$186.755
24-Stunden-Volumen:
2.94M
Relative Volume:
1.69
Marktkapitalisierung:
$28.55B
Einnahmen:
$4.39B
Nettoeinkommen (Verlust:
$853.00M
KGV:
34.25
EPS:
5.5097
Netto-Cashflow:
$556.00M
1W Leistung:
+6.21%
1M Leistung:
+16.08%
6M Leistung:
+40.44%
1J Leistung:
+88.04%
1-Tages-Spanne:
$184.40
$189.46
1-Wochen-Bereich:
$173.24
$189.46
52-Wochen-Spanne:
$88.00
$189.46
Illumina Inc Stock (ILMN) Company Profile
Firmenname
Illumina Inc
Sektor
Branche
Telefon
(858) 202-4500
Adresse
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, IDXX, NTRA, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
188.68 | 26.60B | 4.39B | 853.00M | 556.00M | 5.5097 |
TMO
Thermo Fisher Scientific Inc
|
523.44 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
197.93 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
557.80 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
279.32 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
WAT
Waters Corp
|
379.29 | 36.82B | 3.77B | 449.25M | 240.68M | 7.8556 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Bestätigt | Citigroup | Neutral |
| 2025-02-28 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-02-10 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-11-12 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-08-28 | Hochstufung | Argus | Hold → Buy |
| 2024-08-16 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-01-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-11-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Eingeleitet | Bernstein | Underperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
| 2023-01-25 | Herabstufung | Argus | Buy → Hold |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Perform |
| 2022-12-12 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-04 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Hochstufung | Stifel | Hold → Buy |
| 2022-01-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Underweight |
| 2020-12-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-10-13 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2020-09-21 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-10-25 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Illumina Inc (ILMN) Stock Up 4.6% but GF Value Says Overvalued -- GF Score: 76/100 - GuruFocus
Illumina (ILMN) Gets Bernstein’s Market Perform Rating Amid NovaSeq X Recovery - Insider Monkey
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina stock hits 52-week high at 182.98 USD - Investing.com
Illumina Inc. focuses on sequencing and clinical genomics as investors watch long term growth - AD HOC NEWS
Piper Sandler raises Illumina stock price target on clinical strength - Investing.com
Why Illumina (ILMN) Stock Is Down Today - Yahoo Finance
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Roche takes on Illumina with new NGS system - MedTech Dive
Spatial Genomics and Transcriptomics Market Size to Reach USD 1.90 Billion by 2035, Growing at a 12.23% CAGR | SNS Insider - GlobeNewswire Inc.
Illumina: The Operational Turnaround Is Fully Priced In (NASDAQ:ILMN) - Seeking Alpha
Illumina earnings outlook and consensus, shares on NASDAQ - AD HOC NEWS
The NextSeq 2000 from Illumina Inc.mid-throughput sequencing aims for everyday lab work - AD HOC NEWS
Illumina Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Roche launches Axelios 1 sequencing platform to rival Illumina - BioWorld News
Roche takes aim at Illumina’s dominance with new gene sequencing machine - WNWN-FM
Roche takes aim at Illumina's dominance with new gene sequencing machine - Reuters
Price to earnings forward of Illumina, Inc. – TURQUOISE:ILMNN - TradingView
Illumina shares hold the 200 day line, analysts stay at Hold - AD HOC NEWS
Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip - Yahoo Finance
Roche launches Axelios gene sequencer in a bid to loosen Illumina’s grip - WSAU
Roche Launches AXELIOS 1 Sequencer At $750,000, Targeting Illumina’s Market - insights.citeline.com
Illumina operations and strategy, DNA sequencing leader with NASDAQ-listed shares - AD HOC NEWS
Illumina, Inc. Actuals & Estimates (NASDAQ:ILMN) - TradingView
Illumina at a fresh 52-week high, Bernstein SocGen resumes coverage on the shares - Ad-hoc-news.de
Illumina, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh Actuals & Estimates (BMFBOVESPA:I1LM34) - TradingView
ILMN Forecast — Price Target — Prediction for 2027 - TradingView
Illumina Stock Is Up 32% in 2026: Has the GRAIL Recovery Already Been Priced In? - TIKR.com
Bernstein Maintains Illumina(ILMN.US) With Hold Rating, Announces Target Price $185 - Moomoo
Bernstein SocGen resumes Illumina stock coverage with market perform rating - Investing.com
Illumina chief legal officer sells shares, stock trades near 52-week high - Ad-hoc-news.de
Illumina Inc (ILMN) Institutional Confidence - TradingKey
Illumina, Inc. Actuals & Estimates (HAN:ILU) - TradingView
Illumina chief legal officer sells $110,700 in company stock - Investing.com UK
Illumina chief legal officer sells $110,700 in company stock By Investing.com - Investing.com South Africa
Form 4 Illumina Inc For: 25 June By Investing.com - Investing.com India
Insider Sell: Scott Davies Sells Shares of Illumina Inc (ILMN) - GuruFocus
Illumina (NASDAQ: ILMN) legal chief sells 615 shares in open-market trade - Stock Titan
Form 144 Illumina For: 25 June By Investing.com - Investing.com South Africa
Form 144 ILLUMINA For: 25 June By Investing.com - Investing.com Nigeria
Illumina, Inc. Actuals & Estimates (SIX:ILMN.USD) - TradingView
Illumina (NASDAQ: ILMN) affiliate files Form 144 reporting 98,400-share 10b5-1 sale - Stock Titan
Frances Arnold sells Illumina shares (ILMN) in multiple May–June 2026 trades - Stock Titan
Illumina welcomes Eli Lilly executive, shares react to Barclays target lift - Ad-hoc-news.de
Illumina Inc (ILMN) Stock Up 6.1% but GF Value Says Overvalued -- GF Score: 76/100 - GuruFocus
Why Illumina (ILMN) Stock Is Trading Up Today - Yahoo Finance
Chasing challenges & transforming global health - Illumina
Illumina rises as stronger outlook, buyback support, and bullish analyst sentiment lift shares - Quiver Quantitative
Illumina Jumps 7.7% Amid Sector-Wide Rally - AlphaStreet
Illumina stock hits 52-week high at 177.76 USD By Investing.com - Investing.com Nigeria
Finanzdaten der Illumina Inc-Aktie (ILMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.62%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):